Health & Environmental Research Online (HERO)


Print Feedback Export to File
7041757 
Journal Article 
The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity 
Elkashef, A; Rawson, RA; Smith, E; Pearce, V; Flammino, F; Campbell, J; Donovick, R; Gorodetzky, C; Haning, W; Mawhinney, J; Mccann, M; Weis, D; Williams, L; Ling, W; Vocci, F; , 
2007 
Yes 
Addiction
ISSN: 0965-2140
EISSN: 1360-0443 
WILEY 
HOBOKEN 
107-113 
English 
17493059 
WOS:000244521200012 
In order to increase the number of investigative teams and sites conducting research on pharmacological treatments for methamphetamine use disorders, the National Institute on Drug Abuse (NIDA) established an infrastructure of clinical sites in areas where methamphetamine addiction is prevalent. This multi-site infrastructure would serve to run multiple Phases II and III protocols effectively and expeditiously. 
44th Annual Meeting of the American-College-Neuropsychopharmacology 
Waikoloa, HI